Google’s latest release raises the platform’s research capabilities with structured analysis, clear sourcing, and support for ...

Bristol-Myers Squibb has become the latest drugmaker in the US to file a legal challenge to a block on a drug rebate model opposed by a Health and Human Services (HHS) department. Specifically, BMS is ...

Bristol-Myers Squibb’s drive to build its Opdivo immunotherapy franchise continues, this time with a new FDA filing to treat melanoma in an earlier setting. BMS has asked the FDA for a licence to ...

Bristol Myers Squibb’s highly anticipated Cobenfy just finished its first trip around the sun as an approved drug, posting results in line with expectations that leave investors wondering when an ...

"Karl Weber leaped into the air before the ball had hit the back of the net, his frenzied cheers as indecipherable as the thousands that surrounded him. The entire Cannstatter Kurve had come alive at ...

If you’re looking for the best Windows unzipper, we’ve got you covered. There are some features you shouldn’t overlook, such as speed, reliability, and file type support. Whether you need a quick ...

SUBSCRIBE HERE: <a href=" WRITTEN RECIPE HERE: <a href=" REPLACING THE VODKA: Just substitute the alcohol called for in any ...

BMS and J&J first linked together in 2018 to develop factor X1a inhibitors as anti-coagulants. The three Phase III Librexia ...

Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.

Local AI models offer privacy and zero subscription costs, letting you run powerful models completely offline. Here's how to ...